Navigation Links
Salmon genome in final phases of completion
Date:11/23/2011

The International Cooperation to Sequence the Atlantic Salmon Genome (ICSASG, the "Cooperation") has awarded the Phase II contract for next-generation sequencing and analysis of the Atlantic salmon genome to the J. Craig Venter Institute (JCVI) in Rockville, Maryland. The JCVI will be sequencing the salmon genome using next-generation technologies, including assembly to integrate Sanger and next-generation sequence, and comparative genomics. This effort is expected to generate a high-quality resource for those responsible for the management of wild salmon stocks and the salmon aquaculture industry, as well as providing a reference genome for work with other salmonids.

The Cooperation was formed in 2009 as a partnership between the Research Council of Norway, the Norwegian Fishery and Aquaculture Industry Research Fund, Genome British Columbia, and the Chilean Economic Development Agency (CORFO) and its Innovation Agency InnovaChile. The group brings together expert biologists who have studied salmonids with commercial and government agencies interested in funding further study. Salmonids play a key commercial and environmental role; while some salmon genetic information is known, many fundamental questions remain.

"A fully annotated salmon genome will provide important information about the impact of cultured fish escapees on wild populations, about preservation of populations that are at risk, about strategies for fighting pathogens, and about environmental sustainability issues," says ICSASG chair Dr. Steinar Bergseth at the Research Council of Norway. "A fully assembled reference sequence available for researchers worldwide will have a major impact on research into salmon and other salmonids, such as rainbow trout."

"This is a good example showing that science allows nations and institutions to cooperate on a field where they usually are competitors" says CEO Gonzalo J. Herrera of CONICYT.

"The salmon genome is large and contains repetitive sequences which make it a more difficult genome sequence to assemble. Working with ICSASG, we will complement the Phase I data with next-generation sequence data to provide the most complete salmon genome possible," says Dr. Jason Miller PhD, an associate professor at JCVI.

Worldwide, commercial salmon production exceeds one billion pounds annually, with about 70% coming from aquaculture salmon farms. In addition to being an important economic resource, salmon and other salmonidae species such as trout are considered "sentinel species" for monitoring water quality, and are important markers for ecotoxicology studies.

"This project is a novel approach to addressing issues that are of economic and social importance to aquaculture, conservation, and the environment," says Dr. Alan Winter, President & CEO of Genome BC.


'/>"/>

Contact: Jenny Boon
jboon@genomebc.ca
778-327-8374
Genome BC
Source:Eurekalert

Related biology news :

1. Environmental conditions and predators affect Atlantic salmon survival in the Gulf of Maine
2. Salmon and other fish predators rely on no guts, no glory survival tactic
3. Warming streams could be the end for salmon
4. The same number of fishermen, but less salmon in Spanish rivers
5. Newfound hijacked proteins linked to salmonella virulence
6. E. coli, salmonella may lurk in unwashable places in produce
7. Parasite loads an underlying cause of salmon mortality, linked to land use changes
8. Salmonella stays deadly with a beta version of cell behavior
9. Scientist urges government ruling on genetically engineered salmon
10. Models show Coho salmon at risk in US urbanizing watersheds
11. New target found for nitric oxides attack on salmonella bacteria
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2016)... MINNETONKA, Minn. , Jan. 20, 2016   ... that supports the entire spectrum of clinical research, is ... in 2015. MedNet,s significant achievements are the result of ... of) iMedNet eClinical , it,s comprehensive, ... --> --> Key MedNet growth ...
(Date:1/13/2016)... ALBANY, New York , January 13, 2016 /PRNewswire/ ... Transparency Market Research has published a new market report ... Share, Growth, Trends, and Forecast, 2015 - 2023. According to ... mn in 2014 and is anticipated to reach US$1,625.8 ... from 2015 to 2023. In terms of volume, the ...
(Date:1/8/2016)... and MANCHESTER, United Kingdom , ... a developer of innovative sensor-based diagnostic products, today announced the ... by new and existing investors.  Proceeds from the financing will ... Scanner , a hand-held device for detecting early-stage pressure ulcers. ... Ireland after receiving CE Mark approval. The ...
Breaking Biology News(10 mins):
(Date:2/4/2016)... , Feb. 4, 2016 ContraVir Pharmaceuticals, Inc. ... the development and commercialization of targeted antiviral therapies, announced ... Investor Conference 2016, to be held February 8-9, 2016, ... Group,s 2016 Disruptive Growth & Healthcare Conference, taking place ... 10-11, 2016. James Sapirstein , Chief Executive ...
(Date:2/4/2016)... February 4, 2016 Strasbourg, France ... Inc. --> Strasbourg, France , to ... PharmaVentures is pleased to announce that it acted as ... manufacturing unit in Strasbourg, France , to ... --> --> Transgene (Euronext: TNG), a ...
(Date:2/3/2016)... 3, 2016  With the growing need for ... is underway, therapies such as monoclonal antibodies, recombinant ... host of indications are in high demand. Conventionally ... development and production of these therapeutics. However, due ... high costs, novel approaches and novel expression systems ...
(Date:2/3/2016)... ... February 03, 2016 , ... Aerocom, a world-leading supplier of ... North American healthcare market. , Aerocom Healthcare, LLC will be based in Denver, ... provide new pneumatic tube systems or expand existing systems within the U.S. and ...
Breaking Biology Technology: